Impact Biomedical (IBO) Tax Rate (2022)

Impact Biomedical's (IBO) quarterly Tax Rate came in at 35.82% in Q4 2022, up 127.85% on a QoQ basis from 128.63% in Q3 2022.

Impact Biomedical (IBO) Tax Rate (2022) Analysis & Trends

Impact Biomedical (IBO) has 1 years of Tax Rate data on file, last reported at 35.82% in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.71 Bn	131.86 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	86.87 Bn	78.87 Bn	3.93 Bn	15.11%
3	Argenx Se	65.40 Bn	60.22 Bn	1.37 Bn	10.91%
4	Moderna	59.36 Bn	54.22 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	42.12 Bn	37.02 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.91 Bn	28.60 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.17 Bn	9.78 Bn	668.28 Mn	34.12%
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	-
10	Impact Biomedical	47.30 Mn	47.29 Mn	2,000.00	-

Download Data